Indonesia said it has granted emergency use approval to an mRNA COVID-19 vaccine developed by a Chinese company, becoming the first country, ahead of even China, to do so.

Indonesia’s food and drugs agency greenlighted the use of Walvax Biotechnology’s mRNA vaccine, which has been in development for more than two years and targets the original strain of the coronavirus.…

This data comes from the ChinaPulse.com media intelligence and smart news insights monitoring platform.